Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -130.65% is 11% above its 5-year average of -147.62%, around the middle of its 5-year range (-221.70%–-60.45%).
37.73% below its 12-month average of -94.86%.
Reported quarterly operating margin; no daily interpolation. Q3 FY2026 (2026-06-30): -120.04%.
OPERATING MARGIN
-130.65%
OPERATING MARGIN AVG TTM
-94.86%
OPERATING MARGIN AVG 3Y
-143.12%
OPERATING MARGIN AVG 5Y
-147.62%
OPERATING MARGIN AVG 10Y
-87.70%
OPERATING MARGIN AVG 15Y
-88.64%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-37.73%
CURRENT VS 3Y AVG
+8.71%
CURRENT VS 5Y AVG
+11.50%
CURRENT VS 10Y AVG
-48.97%
CURRENT VS 15Y AVG
-47.39%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Enanta Pharmaceuticals, Inc.
Market Cap
$353.88M
Operating Margin
-130.65%
TTM Avg
-94.86%
3Y Avg
-143.12%
5Y Avg
-147.62%
Market Cap
$353.00M
Operating Margin
24.85%
TTM Avg
23.00%
3Y Avg
24.99%
5Y Avg
31.17%
Market Cap
$352.67M
Operating Margin
-1425.70%
TTM Avg
-1388.03%
3Y Avg
-1860.44%
5Y Avg
-9490.29%
Market Cap
$355.36M
Operating Margin
8.14%
TTM Avg
7.82%
3Y Avg
7.35%
5Y Avg
9.95%
Market Cap
$355.43M
Operating Margin
0.00%
TTM Avg
-13402.79%
3Y Avg
-7027.62%
5Y Avg
-5128.57%
Market Cap
$349.70M
Operating Margin
-154.73%
TTM Avg
-1296.11%
3Y Avg
-1345.68%
5Y Avg
-487.32%
Market Cap
$359.53M
Operating Margin
-14.22%
TTM Avg
-4.51%
3Y Avg
-387.94%
5Y Avg
-2012.06%
Market Cap
$346.73M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$361.64M
Operating Margin
-271.90%
TTM Avg
-418.31%
3Y Avg
-211.58%
5Y Avg
-783.53%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Enanta Pharmaceuticals, Inc. (ENTA) | $353.88M | -130.65% | -94.86% | -143.12% | -147.62% |
| Embecta Corp. (EMBC)vs › | $353.00M | 24.85% | 23.00% | 24.99% | 31.17% |
| Ocugen, Inc. (OCGN)vs › | $352.67M | -1425.70% | -1388.03% | -1860.44% | -9490.29% |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 8.14% | 7.82% | 7.35% | 9.95% |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | 0.00% | -13402.79% | -7027.62% | -5128.57% |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | -154.73% | -1296.11% | -1345.68% | -487.32% |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | -14.22% | -4.51% | -387.94% | -2012.06% |
| Turn Therapeutics Inc. (TTRX)vs › | $346.73M | 0.00% | 0.00% | 0.00% | 0.00% |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | -271.90% | -418.31% | -211.58% | -783.53% |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
98.2%
Operating Margin
-130.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -120.04% |
| 2026-03-31 | -69.07% |
| 2025-12-31 | -60.45% |
| 2025-09-30 | -121.56% |
| 2025-06-30 | -103.16% |
| 2025-03-31 | -164.32% |
| 2024-12-31 | -138.82% |
| 2024-09-30 | -204.38% |
| 2024-06-30 | -134.58% |
| 2024-03-31 | -192.13% |
| 2023-12-31 | -193.78% |
| 2023-09-30 | -163.90% |
| 2023-06-30 | -194.33% |
| 2023-03-31 | -221.70% |
| 2022-12-31 | -127.25% |
| 2022-09-30 | -133.13% |
| 2022-06-30 | -167.05% |
| 2022-03-31 | -180.85% |
| 2021-12-31 | -109.99% |
| 2021-09-30 | -143.06% |
| 2021-06-30 | -156.53% |
| 2021-03-31 | -147.53% |
| 2020-12-31 | -38.75% |
| 2020-09-30 | -83.72% |
| 2020-06-30 | -122.51% |
| 2020-03-31 | -43.00% |
| 2019-12-31 | 24.48% |
| 2019-09-30 | 12.53% |
| 2019-06-30 | 8.46% |
| 2019-03-31 | -3.29% |
| 2018-12-31 | 39.86% |
| 2018-09-30 | 51.26% |
| 2018-06-30 | 39.54% |
| 2018-03-31 | 38.27% |
| 2017-12-31 | 37.73% |
| 2017-09-30 | 71.51% |
| 2017-06-30 | -174.80% |
| 2017-03-31 | -106.11% |
| 2016-12-31 | -67.64% |
| 2016-09-30 | -24.13% |
| 2016-06-30 | -7.79% |
| 2016-03-31 | -4.34% |
| 2015-12-31 | 73.47% |
| 2015-09-30 | 25.49% |
| 2015-06-30 | 14.68% |
| 2015-03-31 | 84.65% |
| 2014-12-31 | 90.60% |
| 2014-09-30 | -201.97% |
| 2014-06-30 | 82.98% |
| 2014-03-31 | -237.36% |
| 2013-12-31 | -611.09% |
| 2013-09-30 | -348.48% |
| 2013-06-30 | -253.37% |
| 2013-03-31 | -334.53% |
| 2012-12-31 | 78.64% |
| 2012-09-30 | -224.38% |
| 2012-06-30 | -138.79% |
| 2012-03-31 | 87.78% |
| 2011-12-31 | -429.42% |
| 2011-09-30 | 0.00% |
